The effect of VAV3 polymorphisms on thyroid cancer

被引:1
|
作者
Ren, Wanli [1 ]
Xu, Chongwen [1 ]
Wang, Shiyang [1 ]
Li, Huajing [1 ]
Dai, Hao [1 ]
Yang, Fangli [1 ]
Shao, Yuan [1 ]
Bai, Yanxia [1 ]
机构
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Otorhinolaryngol Head & Neck Surg, Xian 710061, Shaanxi, Peoples R China
关键词
Thyroid cancer; Risk factors; VAV3; polymorphisms; Case-control study; RISK; ASSOCIATION; DISEASE; IMPACT;
D O I
10.1007/s12020-021-02827-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The incidence of thyroid cancer is rising rapidly in China, but there are few studies on the risk factors of thyroid cancer in the Chinese Han population. Methods We performed this case-control study of 510 patients and 509 controls to for determine the linkage of VAV3 variants (rs17019602, rs7521681, rs4915076, and rs1777451) with thyroid cancer susceptibility by computing the odds ratio (OR) and 95% confidence intervals (CI). Multi-factor dimension reduction (MDR) analysis was conducted to assess interaction of VAV3 genetic variants. Results We found that rs7521681 was remarkably related to a higher risk of thyroid cancer (OR = 1.74, p = 0.012), whereas rs4915076 (OR = 0.66, p = 0.001) significantly decreased thyroid cancer susceptibility. Stratified analyses showed that rs4915076 had a protective role in thyroid cancer in both ages >45 years (OR = 0.70, p = 0.017) and age <= 45 years (OR = 0.63, p = 0.007). Rs17019602 could increase the susceptibility of thyroid cancer in men (OR = 4.76, p = 0.049). Rs7521681 was related to an increased risk of thyroid cancer in women (OR = 1.97, p = 0.012). Rs4915076 could protect individuals from thyroid cancer both in men (OR = 0.60, p = 0.031) and women (OR = 0.68, p = 0.010). Moreover, rs4915076 was the best single-locus model to predict thyroid cancer. Interestingly, the interaction model of rs17019602, rs7521681, rs4915076, rs1777451, and age was a candidate gene-environment model. Conclusion Our results indicated VAV3 variants were associated with thyroid cancer, which provides a new sight into etiology of thyroid cancer.
引用
收藏
页码:178 / 184
页数:7
相关论文
共 50 条
  • [1] The effect of VAV3 polymorphisms on thyroid cancer
    Wanli Ren
    Chongwen Xu
    Shiyang Wang
    Huajing Li
    Hao Dai
    Fangli Yang
    Yuan Shao
    Yanxia Bai
    Endocrine, 2022, 75 : 178 - 184
  • [2] Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
    Nuria Perretta-Tejedor
    Javier Fernández-Mateos
    Luis García-Ortiz
    Manuel A. Gómez-Marcos
    José I. Recio-Rodríguez
    Cristina Agudo-Conde
    Emiliano Rodriguez-Sánchez
    Ana I. Morales
    Francisco J. López-Hernández
    José M. López-Novoa
    Rogelio González-Sarmiento
    Carlos Martínez-Salgado
    Scientific Reports, 7
  • [3] Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
    Perretta-Tejedor, Nuria
    Fernandez-Mateos, Javier
    Garcia-Ortiz, Luis
    Gomez-Marcos, Manuel A.
    Recio-Rodriguez, Jose I.
    Agudo-Conde, Cristina
    Rodriguez-Sanchez, Emiliano
    Morales, Ana I.
    Lopez-Hernandez, Francisco J.
    Lopez-Novoa, Jose M.
    Gonzalez-Sarmiento, Rogelio
    Martinez-Salgado, Carlos
    SCIENTIFIC REPORTS, 2017, 7
  • [4] Correction: Corrigendum: Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors
    Nuria Perretta-Tejedor
    Javier Fernández-Mateos
    Luis García-Ortiz
    Manuel A. Gómez-Marcos
    José I. Recio-Rodríguez
    Cristina Agudo-Conde
    Emiliano Rodriguez-Sánchez
    Ana I. Morales
    Francisco J. López-Hernández
    José M. López-Novoa
    Rogelio González-Sarmiento
    Carlos Martínez-Salgado
    Scientific Reports, 8
  • [5] Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors (vol 7, 2017)
    Perretta-Tejedor, Nuria
    Fernandez-Mateos, Javier
    Garcia-Ortiz, Luis
    Gomez-Marcos, Manuel A.
    Recio-Rodriguez, Jose I.
    Agudo-Conde, Cristina
    Rodriguez-Sanchez, Emiliano
    Morales, Ana I.
    Lopez-Hernandez, Francisco J.
    Lopez-Novoa, Jose M.
    Gonzalez-Sarmiento, Rogelio
    Martinez-Salgado, Carlos
    SCIENTIFIC REPORTS, 2018, 8
  • [6] VAV3 mediates resistance to breast cancer endocrine therapy
    Helena Aguilar
    Ander Urruticoechea
    Pasi Halonen
    Kazuma Kiyotani
    Taisei Mushiroda
    Xavier Barril
    Jordi Serra-Musach
    Abul Islam
    Livia Caizzi
    Luciano Di Croce
    Ekaterina Nevedomskaya
    Wilbert Zwart
    Josefine Bostner
    Elin Karlsson
    Gizeh Pérez Tenorio
    Tommy Fornander
    Dennis C Sgroi
    Rafael Garcia-Mata
    Maurice PHM Jansen
    Nadia García
    Núria Bonifaci
    Fina Climent
    María Teresa Soler
    Alejo Rodríguez-Vida
    Miguel Gil
    Joan Brunet
    Griselda Martrat
    Laia Gómez-Baldó
    Ana I Extremera
    Agnes Figueras
    Josep Balart
    Robert Clarke
    Kerry L Burnstein
    Kathryn E Carlson
    John A Katzenellenbogen
    Miguel Vizoso
    Manel Esteller
    Alberto Villanueva
    Ana B Rodríguez-Peña
    Xosé R Bustelo
    Yusuke Nakamura
    Hitoshi Zembutsu
    Olle Stål
    Roderick L Beijersbergen
    Miguel Angel Pujana
    Breast Cancer Research, 16
  • [7] VAV3 mediates resistance to breast cancer endocrine therapy
    Aguilar, Helena
    Urruticoechea, Ander
    Halonen, Pasi
    Kiyotani, Kazuma
    Mushiroda, Taisei
    Barril, Xavier
    Serra-Musach, Jordi
    Islam, Abul
    Caizzi, Livia
    Di Croce, Luciano
    Nevedomskaya, Ekaterina
    Zwart, Wilbert
    Bostner, Josefine
    Karlsson, Elin
    Tenorio, Gizeh Perez
    Fornander, Tommy
    Sgroi, Dennis C.
    Garcia-Mata, Rafael
    Jansen, Maurice P. H. M.
    Garcia, Nadia
    Bonifaci, Nuria
    Climent, Fina
    Teresa Soler, Maria
    Rodriguez-Vida, Alejo
    Gil, Miguel
    Brunet, Joan
    Martrat, Griselda
    Gomez-Baldo, Laia
    Extremera, Ana I.
    Figueras, Agnes
    Balart, Josep
    Clarke, Robert
    Burnstein, Kerry L.
    Carlson, Kathryn E.
    Katzenellenbogen, John A.
    Vizoso, Miguel
    Esteller, Manel
    Villanueva, Alberto
    Rodriguez-Pena, Ana B.
    Bustelo, Xose R.
    Nakamura, Yusuke
    Zembutsu, Hitoshi
    Stal, Olle
    Beijersbergen, Roderick L.
    Angel Pujana, Miguel
    BREAST CANCER RESEARCH, 2014, 16 (03)
  • [8] Regeneration after death: Vav3 to the rescue
    D'mello, Veera
    Birge, Raymond B.
    BLOOD, 2009, 113 (21) : 5037 - 5038
  • [9] VAV3 rs7528153 and VAV3-AS1 rs1185222 polymorphisms are associated with an increased risk of developing hypertension
    Pablo Miramontes-Gonzalez, Jose
    Usategui-Martin, Ricardo
    Martin-Vallejo, Javier
    Ziegler, Michael
    Lopez de Isla, Leopoldo
    O'Connor, Daniel
    Gonzalez-Sarmiento, Rogelio
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 80 : 60 - 65
  • [10] Expression of Vav3 protein and its prognostic value in patients with gastric cancer
    Tan, Bibo
    Li, Yong
    Shi, Xiaoming
    Fan, Liqiao
    Zhao, Qun
    Liu, Yanli
    Tan, Ming
    Liu, Qingwei
    Jia, Nan
    PATHOLOGY RESEARCH AND PRACTICE, 2017, 213 (05) : 435 - 440